Christopher Sweeney on the Future of Prostate Cancer Care
Christopher Sweeney, MBBS, Medical Oncologist, gives us his insight on the future of prostate cancer care and research in the year 2027.
Christopher Sweeney, MBBS, Medical Oncologist, gives us his insight on the future of prostate cancer care and research in the year 2027.
Continuing his discussion at the AUA 2024 Annual Meeting, Dr. Narayan highlights the latest news on nadofaragene firadenovec.
Tom and Brian are joined by David Penson to discuss upcoming presentations to look forward to at AUA, including new muscle-invasive bladder cancer research.
The utility of cADT in patients with prostate cancer with clinical relapse at PSMA PET is unknown.
Results from the third interim analysis of the DAROL study indicate real-world effectiveness in patients with nmCRPC.
Identifying tumor biomarkers associated with pCR to neoadjuvant pembro or NAC prior to cystectomy in patients with MIBC.
Read in-depth coverage of the AUA 2024 Annual Meeting, featuring the latest research and science on urology from GU oncology experts and key opinion leaders.
Sunday, May 5, 2024 7:50 AM to 8:00 AM · 10 min. (US/Central)
Read in-depth coverage of the AUA 2024 Annual Meeting, featuring the latest research and science on urology from GU oncology experts and key opinion leaders.
In data presented at AUA 2024, researchers sought to determine if ctDNA detection prior to radical cystectomy is linked to poor outcomes and lymph node…
Read in-depth coverage of the AUA 2024 Annual Meeting, featuring the latest research and science on urology from GU oncology experts and key opinion leaders.